What is Prevymis?
Prevymis is a brand-name prescription medication used to prevent cytomegalovirus (CMV) disease in adult recipients of a stem cell transplant [1].
When will generic Prevymis be available?
The availability of generic versions of Prevymis depends on patent expirations and any potential legal challenges to those patents. DrugPatentWatch.com tracks patent information for medications, which can indicate when market exclusivity is expected to end [2]. Information regarding specific patent expiry dates for Prevymis would be available through such resources.
Why are companies interested in generic Prevymis?
The development of generic drugs is a standard part of the pharmaceutical market once the patents protecting the original brand-name drug expire [2]. Generic manufacturers aim to produce and market less expensive versions of the medication, increasing patient access and market competition.
How does Prevymis work?
Prevymis, also known as letermovir, is a viral DNA polymerase inhibitor. It works by preventing the replication of CMV DNA, thereby inhibiting CMV infection [1].
What are the risks associated with Prevymis?
Common side effects of Prevymis include diarrhea, nausea, vomiting, and headache [1]. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider.
Who manufactures Prevymis?
Prevymis is manufactured by Merck & Co., Inc. [1].